umlaut_journal_tocs 0.0.1

This diff represents the content of publicly available package versions that have been released to one of the supported registries. The information contained in this diff is provided for informational purposes only and reflects changes between package versions as they appear in their respective public registries.
Files changed (62) hide show
  1. checksums.yaml +7 -0
  2. data/MIT-LICENSE +20 -0
  3. data/Rakefile +37 -0
  4. data/app/item_decorators/umlaut_journal_tocs_decorator.rb +50 -0
  5. data/app/service_adaptors/journal_tocs_adapter.rb +51 -0
  6. data/app/views/umlaut_journal_tocs/_bento_item.html.erb +80 -0
  7. data/app/views/umlaut_journal_tocs/_resolve_section.html.erb +10 -0
  8. data/config/locales/en.yml +5 -0
  9. data/config/routes.rb +2 -0
  10. data/lib/tasks/umlaut_journal_tocs_tasks.rake +4 -0
  11. data/lib/umlaut_journal_tocs.rb +26 -0
  12. data/lib/umlaut_journal_tocs/engine.rb +18 -0
  13. data/lib/umlaut_journal_tocs/version.rb +3 -0
  14. data/test/controller_test.rb +36 -0
  15. data/test/dummy/README.rdoc +28 -0
  16. data/test/dummy/Rakefile +6 -0
  17. data/test/dummy/app/assets/javascripts/application.js +17 -0
  18. data/test/dummy/app/assets/stylesheets/application.css +19 -0
  19. data/test/dummy/app/controllers/application_controller.rb +5 -0
  20. data/test/dummy/app/controllers/umlaut_controller.rb +136 -0
  21. data/test/dummy/app/helpers/application_helper.rb +2 -0
  22. data/test/dummy/app/views/layouts/application.html.erb +14 -0
  23. data/test/dummy/bin/bundle +3 -0
  24. data/test/dummy/bin/rails +4 -0
  25. data/test/dummy/bin/rake +4 -0
  26. data/test/dummy/bin/setup +29 -0
  27. data/test/dummy/config.ru +4 -0
  28. data/test/dummy/config/application.rb +26 -0
  29. data/test/dummy/config/boot.rb +5 -0
  30. data/test/dummy/config/database.yml +60 -0
  31. data/test/dummy/config/environment.rb +5 -0
  32. data/test/dummy/config/environments/development.rb +45 -0
  33. data/test/dummy/config/environments/production.rb +83 -0
  34. data/test/dummy/config/environments/test.rb +42 -0
  35. data/test/dummy/config/initializers/assets.rb +11 -0
  36. data/test/dummy/config/initializers/backtrace_silencers.rb +7 -0
  37. data/test/dummy/config/initializers/cookies_serializer.rb +3 -0
  38. data/test/dummy/config/initializers/filter_parameter_logging.rb +4 -0
  39. data/test/dummy/config/initializers/inflections.rb +16 -0
  40. data/test/dummy/config/initializers/mime_types.rb +4 -0
  41. data/test/dummy/config/initializers/session_store.rb +3 -0
  42. data/test/dummy/config/initializers/umlaut_journal_tocs.rb +20 -0
  43. data/test/dummy/config/initializers/wrap_parameters.rb +14 -0
  44. data/test/dummy/config/locales/en.yml +23 -0
  45. data/test/dummy/config/routes.rb +57 -0
  46. data/test/dummy/config/secrets.yml +22 -0
  47. data/test/dummy/config/umlaut_services.yml +23 -0
  48. data/test/dummy/db/migrate/20150901192508_umlaut_init.umlaut.rb +106 -0
  49. data/test/dummy/db/migrate/20150901192509_umlaut_add_service_response_index.umlaut.rb +10 -0
  50. data/test/dummy/db/schema.rb +118 -0
  51. data/test/dummy/public/404.html +67 -0
  52. data/test/dummy/public/422.html +67 -0
  53. data/test/dummy/public/500.html +66 -0
  54. data/test/dummy/public/favicon.ico +0 -0
  55. data/test/journal_tocs_adapter_test.rb +93 -0
  56. data/test/support/vcr_filter.rb +45 -0
  57. data/test/test_helper.rb +39 -0
  58. data/test/vcr_cassettes/generates_no_response.yml +49 -0
  59. data/test/vcr_cassettes/generates_response.yml +952 -0
  60. data/test/vcr_cassettes/gets_results.yml +804 -0
  61. data/test/vcr_cassettes/registers_proper_error.yml +40 -0
  62. metadata +200 -0
@@ -0,0 +1,67 @@
1
+ <!DOCTYPE html>
2
+ <html>
3
+ <head>
4
+ <title>The page you were looking for doesn't exist (404)</title>
5
+ <meta name="viewport" content="width=device-width,initial-scale=1">
6
+ <style>
7
+ body {
8
+ background-color: #EFEFEF;
9
+ color: #2E2F30;
10
+ text-align: center;
11
+ font-family: arial, sans-serif;
12
+ margin: 0;
13
+ }
14
+
15
+ div.dialog {
16
+ width: 95%;
17
+ max-width: 33em;
18
+ margin: 4em auto 0;
19
+ }
20
+
21
+ div.dialog > div {
22
+ border: 1px solid #CCC;
23
+ border-right-color: #999;
24
+ border-left-color: #999;
25
+ border-bottom-color: #BBB;
26
+ border-top: #B00100 solid 4px;
27
+ border-top-left-radius: 9px;
28
+ border-top-right-radius: 9px;
29
+ background-color: white;
30
+ padding: 7px 12% 0;
31
+ box-shadow: 0 3px 8px rgba(50, 50, 50, 0.17);
32
+ }
33
+
34
+ h1 {
35
+ font-size: 100%;
36
+ color: #730E15;
37
+ line-height: 1.5em;
38
+ }
39
+
40
+ div.dialog > p {
41
+ margin: 0 0 1em;
42
+ padding: 1em;
43
+ background-color: #F7F7F7;
44
+ border: 1px solid #CCC;
45
+ border-right-color: #999;
46
+ border-left-color: #999;
47
+ border-bottom-color: #999;
48
+ border-bottom-left-radius: 4px;
49
+ border-bottom-right-radius: 4px;
50
+ border-top-color: #DADADA;
51
+ color: #666;
52
+ box-shadow: 0 3px 8px rgba(50, 50, 50, 0.17);
53
+ }
54
+ </style>
55
+ </head>
56
+
57
+ <body>
58
+ <!-- This file lives in public/404.html -->
59
+ <div class="dialog">
60
+ <div>
61
+ <h1>The page you were looking for doesn't exist.</h1>
62
+ <p>You may have mistyped the address or the page may have moved.</p>
63
+ </div>
64
+ <p>If you are the application owner check the logs for more information.</p>
65
+ </div>
66
+ </body>
67
+ </html>
@@ -0,0 +1,67 @@
1
+ <!DOCTYPE html>
2
+ <html>
3
+ <head>
4
+ <title>The change you wanted was rejected (422)</title>
5
+ <meta name="viewport" content="width=device-width,initial-scale=1">
6
+ <style>
7
+ body {
8
+ background-color: #EFEFEF;
9
+ color: #2E2F30;
10
+ text-align: center;
11
+ font-family: arial, sans-serif;
12
+ margin: 0;
13
+ }
14
+
15
+ div.dialog {
16
+ width: 95%;
17
+ max-width: 33em;
18
+ margin: 4em auto 0;
19
+ }
20
+
21
+ div.dialog > div {
22
+ border: 1px solid #CCC;
23
+ border-right-color: #999;
24
+ border-left-color: #999;
25
+ border-bottom-color: #BBB;
26
+ border-top: #B00100 solid 4px;
27
+ border-top-left-radius: 9px;
28
+ border-top-right-radius: 9px;
29
+ background-color: white;
30
+ padding: 7px 12% 0;
31
+ box-shadow: 0 3px 8px rgba(50, 50, 50, 0.17);
32
+ }
33
+
34
+ h1 {
35
+ font-size: 100%;
36
+ color: #730E15;
37
+ line-height: 1.5em;
38
+ }
39
+
40
+ div.dialog > p {
41
+ margin: 0 0 1em;
42
+ padding: 1em;
43
+ background-color: #F7F7F7;
44
+ border: 1px solid #CCC;
45
+ border-right-color: #999;
46
+ border-left-color: #999;
47
+ border-bottom-color: #999;
48
+ border-bottom-left-radius: 4px;
49
+ border-bottom-right-radius: 4px;
50
+ border-top-color: #DADADA;
51
+ color: #666;
52
+ box-shadow: 0 3px 8px rgba(50, 50, 50, 0.17);
53
+ }
54
+ </style>
55
+ </head>
56
+
57
+ <body>
58
+ <!-- This file lives in public/422.html -->
59
+ <div class="dialog">
60
+ <div>
61
+ <h1>The change you wanted was rejected.</h1>
62
+ <p>Maybe you tried to change something you didn't have access to.</p>
63
+ </div>
64
+ <p>If you are the application owner check the logs for more information.</p>
65
+ </div>
66
+ </body>
67
+ </html>
@@ -0,0 +1,66 @@
1
+ <!DOCTYPE html>
2
+ <html>
3
+ <head>
4
+ <title>We're sorry, but something went wrong (500)</title>
5
+ <meta name="viewport" content="width=device-width,initial-scale=1">
6
+ <style>
7
+ body {
8
+ background-color: #EFEFEF;
9
+ color: #2E2F30;
10
+ text-align: center;
11
+ font-family: arial, sans-serif;
12
+ margin: 0;
13
+ }
14
+
15
+ div.dialog {
16
+ width: 95%;
17
+ max-width: 33em;
18
+ margin: 4em auto 0;
19
+ }
20
+
21
+ div.dialog > div {
22
+ border: 1px solid #CCC;
23
+ border-right-color: #999;
24
+ border-left-color: #999;
25
+ border-bottom-color: #BBB;
26
+ border-top: #B00100 solid 4px;
27
+ border-top-left-radius: 9px;
28
+ border-top-right-radius: 9px;
29
+ background-color: white;
30
+ padding: 7px 12% 0;
31
+ box-shadow: 0 3px 8px rgba(50, 50, 50, 0.17);
32
+ }
33
+
34
+ h1 {
35
+ font-size: 100%;
36
+ color: #730E15;
37
+ line-height: 1.5em;
38
+ }
39
+
40
+ div.dialog > p {
41
+ margin: 0 0 1em;
42
+ padding: 1em;
43
+ background-color: #F7F7F7;
44
+ border: 1px solid #CCC;
45
+ border-right-color: #999;
46
+ border-left-color: #999;
47
+ border-bottom-color: #999;
48
+ border-bottom-left-radius: 4px;
49
+ border-bottom-right-radius: 4px;
50
+ border-top-color: #DADADA;
51
+ color: #666;
52
+ box-shadow: 0 3px 8px rgba(50, 50, 50, 0.17);
53
+ }
54
+ </style>
55
+ </head>
56
+
57
+ <body>
58
+ <!-- This file lives in public/500.html -->
59
+ <div class="dialog">
60
+ <div>
61
+ <h1>We're sorry, but something went wrong.</h1>
62
+ </div>
63
+ <p>If you are the application owner check the logs for more information.</p>
64
+ </div>
65
+ </body>
66
+ </html>
File without changes
@@ -0,0 +1,93 @@
1
+ require 'test_helper'
2
+
3
+ class JournalTocsAdapterTest < ActiveSupport::TestCase
4
+ extend TestWithCassette
5
+
6
+ before do
7
+ @service_config = {
8
+ "type" => "JournalTocsAdapter",
9
+ "priority" => 1
10
+ }
11
+ @service_config_list = {'default' => {
12
+ "services" => {
13
+ "journal_tocs" => @service_config
14
+ }
15
+ }
16
+ }
17
+
18
+ @service = JournalTocsAdapter.new(@service_config.merge("service_id" => "journal_tocs"))
19
+ end
20
+
21
+ describe "with no ISSN" do
22
+ test "does nothing" do
23
+ umlaut_request = fake_umlaut_request("/resolve?jtitle=Journal+Of+Something&genre=journal")
24
+
25
+ @service.handle(umlaut_request)
26
+
27
+ assert_dispatched umlaut_request, "journal_tocs"
28
+ assert_service_responses umlaut_request, 'journal_tocs', :number => 0
29
+ end
30
+ end
31
+
32
+ describe "article-level citation" do
33
+ test "does nothing" do
34
+ @umlaut_request = fake_umlaut_request("/resolve?jtitle=JAMA&genre=article&issn=1538-3598&volume=1&issue=1&spage=1")
35
+ @service.handle(@umlaut_request)
36
+
37
+ assert_dispatched @umlaut_request, "journal_tocs"
38
+ response = assert_service_responses @umlaut_request, 'journal_tocs', :number => 0
39
+ end
40
+ end
41
+
42
+ describe "with ISSN that works" do
43
+ before do
44
+ @umlaut_request = fake_umlaut_request("/resolve?au=JAMA&genre=journal&issn=1538-3598")
45
+ end
46
+
47
+ test_with_cassette "generates response" do
48
+ @service.handle(@umlaut_request)
49
+
50
+ assert_dispatched @umlaut_request, "journal_tocs"
51
+ response = assert_service_responses @umlaut_request, 'journal_tocs', :number => 1
52
+
53
+ # Can we de-serialize?
54
+ bento_results = BentoSearch::Results.load_json(response.service_data)
55
+
56
+ assert_kind_of BentoSearch::Results, bento_results
57
+ assert bento_results.count > 0
58
+ bento_results.each do |result|
59
+ assert_kind_of BentoSearch::ResultItem, result
60
+ end
61
+ end
62
+ end
63
+
64
+ describe "with ISSN with no JournalTocs results" do
65
+ before do
66
+ @umlaut_request = fake_umlaut_request("/resolve?au=JAMA&genre=journal&issn=12345678")
67
+ end
68
+
69
+ test_with_cassette("generates no response") do
70
+ @service.handle(@umlaut_request)
71
+
72
+ assert_dispatched @umlaut_request, "journal_tocs"
73
+ assert_service_responses @umlaut_request, 'journal_tocs', :number => 0
74
+ end
75
+ end
76
+
77
+ describe "with bad email" do
78
+ before do
79
+ config = @service_config.merge("service_id" => "journal_tocs",
80
+ "bento_search_engine" => "bad_email_journal_tocs")
81
+ @service = JournalTocsAdapter.new(config)
82
+
83
+ @umlaut_request = fake_umlaut_request("/resolve?au=JAMA&genre=journal&issn=12345678")
84
+ end
85
+ test_with_cassette "registers proper error" do
86
+ @service.handle(@umlaut_request)
87
+
88
+ assert_dispatched @umlaut_request, "journal_tocs", "failed_temporary"
89
+ assert_service_responses @umlaut_request, 'journal_tocs', :number => 0
90
+ end
91
+ end
92
+
93
+ end
@@ -0,0 +1,45 @@
1
+ require 'vcr'
2
+
3
+ # Convenience for using VCR's filter_sensitive_data according to our common
4
+ # pattern.
5
+ #
6
+ # For a sensitive piece of information, set in your shell environment variable eg:
7
+ #
8
+ # BD_FINDITEM_PATRON="patron_barcode"
9
+ #
10
+ # Then call in a test:
11
+ # VCRFilter.sensitive_data! :bd_finditem_patron
12
+ #
13
+ # In the tests, when you need to use the piece of data somewhere, use
14
+ # VCRFilter[:bd_library_symbol]
15
+ #
16
+ # eg
17
+ # BorrowDirect::FindItem.new(VCRFilter[:bd_finditem_patron])
18
+ #
19
+ # Optional but recommended, use VCR cassette tags...
20
+ # VCRFilter.sensitive_data!, :bd_finditem_patron, :bd_finditem_tests
21
+ # #...
22
+ # describe "BD finditem items", :vcr => {:tag => :bd_finditem_tests}
23
+ #
24
+ # When recording a new cassette, the value from ENV will be used in interactions
25
+ # with remote service, but won't be saved in your on disk cassettes -- it will
26
+ # be saved as eg DUMMY_BD_FINDITEM_PATRON instead.
27
+ #
28
+ # When running from recorded cassettes, you don't need to have the ENV defined, but
29
+ # when (re-)recording a cassette, you of course do.
30
+ module VCRFilter
31
+ @@data = {}
32
+ def self.[](key) ; @@data[key.to_s.downcase] ; end
33
+ def self.[]=(key, value) ; @@data[key.to_s.downcase] = value ; end
34
+
35
+ def self.sensitive_data!(key, vcr_tag = nil)
36
+ env_key = key.to_s.upcase
37
+ dummy_value = "DUMMY_#{env_key}"
38
+
39
+ self[key] = (ENV[env_key] || dummy_value)
40
+
41
+ VCR.configure do |c|
42
+ c.filter_sensitive_data( dummy_value, vcr_tag ) { self[key] }
43
+ end
44
+ end
45
+ end
@@ -0,0 +1,39 @@
1
+ # Configure Rails Environment
2
+ ENV["RAILS_ENV"] = "test"
3
+
4
+ require File.expand_path("../../test/dummy/config/environment.rb", __FILE__)
5
+ ActiveRecord::Migrator.migrations_paths = [File.expand_path("../../test/dummy/db/migrate", __FILE__)]
6
+ require "rails/test_help"
7
+
8
+ require 'minitest-spec-rails'
9
+
10
+ require 'umlaut'
11
+ require 'umlaut/test_help'
12
+ include Umlaut::TestHelp
13
+
14
+ # Filter out Minitest backtrace while allowing backtrace from other libraries
15
+ # to be shown.
16
+ Minitest.backtrace_filter = Minitest::BacktraceFilter.new
17
+
18
+ # Load support files
19
+ Dir["#{File.dirname(__FILE__)}/support/**/*.rb"].each do |f|
20
+ require f
21
+ end
22
+
23
+
24
+
25
+ # Load fixtures from the engine
26
+ if ActiveSupport::TestCase.respond_to?(:fixture_path=)
27
+ ActiveSupport::TestCase.fixture_path = File.expand_path("../fixtures", __FILE__)
28
+ ActiveSupport::TestCase.fixtures :all
29
+ end
30
+
31
+ if defined?(VCR)
32
+ VCR.configure do |c|
33
+ c.cassette_library_dir = 'test/vcr_cassettes'
34
+ c.hook_into :webmock # or :fakeweb
35
+ end
36
+ end
37
+
38
+ VCRFilter.sensitive_data! :journal_tocs_email
39
+
@@ -0,0 +1,49 @@
1
+ ---
2
+ http_interactions:
3
+ - request:
4
+ method: get
5
+ uri: http://www.journaltocs.ac.uk/api/journals/12345678?output=articles&user=DUMMY_JOURNAL_TOCS_EMAIL
6
+ body:
7
+ encoding: UTF-8
8
+ string: ''
9
+ headers:
10
+ User-Agent:
11
+ - HTTPClient/1.0 (2.6.0.1, ruby 2.2.2 (2015-04-13))
12
+ Accept:
13
+ - "*/*"
14
+ Date:
15
+ - Thu, 03 Sep 2015 20:09:21 GMT
16
+ response:
17
+ status:
18
+ code: 200
19
+ message: OK
20
+ headers:
21
+ Date:
22
+ - Thu, 03 Sep 2015 20:09:21 GMT
23
+ Server:
24
+ - Apache
25
+ X-Powered-By:
26
+ - PHP/5.3.3
27
+ Content-Length:
28
+ - '1192'
29
+ Content-Type:
30
+ - application/xml; charset=utf-8
31
+ body:
32
+ encoding: UTF-8
33
+ string: "<?xml version=\"1.0\" encoding=\"utf-8\"?>\n<rdf:RDF xmlns:rdf=\"http://www.w3.org/1999/02/22-rdf-syntax-ns#\"\r\n
34
+ \ xmlns=\"http://purl.org/rss/1.0/\"\r\n xmlns:mn=\"http://usefulinc.com/rss/manifest/\"\r\n
35
+ \ xmlns:dc=\"http://purl.org/dc/elements/1.1/\">\n\n <channel rdf:about=\"http://www.journaltocs.hw.ac.uk/api/journals\">\r\n
36
+ \ <title>JournalTOCs API - Found 0 journals for: 12345678 (0 articles)</title>\r\n
37
+ \ <link>http://www.journaltocs.ac.uk/api/journals/12345678</link>\r\n <description><![CDATA[Your
38
+ query: 12345678 has returned 0 articles. Table of contents is currently unavailable
39
+ for this journal. Please report to S.Chumbe@hw.ac.uk]]></description>\r\n
40
+ \ <dc:publisher>JournalTOCs API</dc:publisher>\r\n <dc:creator>JOURNALTOCS
41
+ API PROJECT</dc:creator>\r\n\t\t<dc:coverage>0</dc:coverage>\r\n <image
42
+ rdf:resource=\"http://www.journaltocs.ac.uk/images/jtocslogo.gif\" />\r\n
43
+ \ <items>\r\n <rdf:Seq>\r\n </rdf:Seq>\r\n </items>\r\n </channel>\r\n
44
+ \ \r\n\t\r\n <rdf:Description rdf:ID=\"manifest\">\r\n <mn:channels>\r\n
45
+ \ <rdf:Seq>\r\n <rdf:li rdf:resource=\"http://www.journaltocs.hw.ac.uk/api/journals\"
46
+ />\r\n </rdf:Seq>\r\n </mn:channels>\r\n </rdf:Description>\r\n\r\n</rdf:RDF>"
47
+ http_version:
48
+ recorded_at: Thu, 03 Sep 2015 20:09:21 GMT
49
+ recorded_with: VCR 2.9.3
@@ -0,0 +1,952 @@
1
+ ---
2
+ http_interactions:
3
+ - request:
4
+ method: get
5
+ uri: http://www.journaltocs.ac.uk/api/journals/15383598?output=articles&user=DUMMY_JOURNAL_TOCS_EMAIL
6
+ body:
7
+ encoding: UTF-8
8
+ string: ''
9
+ headers:
10
+ User-Agent:
11
+ - HTTPClient/1.0 (2.6.0.1, ruby 2.2.2 (2015-04-13))
12
+ Accept:
13
+ - "*/*"
14
+ Date:
15
+ - Thu, 03 Sep 2015 20:09:19 GMT
16
+ response:
17
+ status:
18
+ code: 200
19
+ message: OK
20
+ headers:
21
+ Date:
22
+ - Thu, 03 Sep 2015 20:09:20 GMT
23
+ Server:
24
+ - Apache
25
+ X-Powered-By:
26
+ - PHP/5.3.3
27
+ Transfer-Encoding:
28
+ - chunked
29
+ Content-Type:
30
+ - application/xml; charset=utf-8
31
+ body:
32
+ encoding: UTF-8
33
+ string: "<?xml version=\"1.0\" encoding=\"UTF-8\"?>\n<rdf:RDF xmlns:rdf=\"http://www.w3.org/1999/02/22-rdf-syntax-ns#\"
34
+ \r\n xmlns:prism=\"http://prismstandard.org/namespaces/1.2/basic/\"
35
+ \r\n\t\t\t\t xmlns:dc=\"http://purl.org/dc/elements/1.1/\" \r\n\t\t\t\t xmlns:mn=\"http://usefulinc.com/rss/manifest/\"\r\n\t\t\t\t
36
+ xmlns:content=\"http://purl.org/rss/1.0/modules/content/\" \r\n\t\t\t\t xmlns=\"http://purl.org/rss/1.0/\">\n\n
37
+ \ <channel rdf:about=\"http://www.journaltocs.hw.ac.uk/api/journals\">\r\n
38
+ \ <title>JournalTOCs API - JAMA The Journal of the American Medical Association
39
+ (38 articles)</title>\r\n <link>http://www.journaltocs.ac.uk/api/journals/15383598</link>\r\n
40
+ \ <description><![CDATA[Your query: 15383598 has returned 38 articles. They
41
+ are listed in alphabetical order per journal (maximum number of returned items
42
+ is 3000).]]></description>\r\n <dc:publisher>JournalTOCs API</dc:publisher>\r\n
43
+ \ <dc:creator>JOURNALTOCS API PROJECT</dc:creator>\r\n\t\t<dc:coverage>1</dc:coverage>\r\n
44
+ \ <image rdf:resource=\"http://www.journaltocs.ac.uk/images/jtocslogo.gif\"
45
+ />\r\n <items>\r\n <rdf:Seq><rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429716\"
46
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429719\"
47
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429717\"
48
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429702\"
49
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429693\"
50
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429712\"
51
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429698\"
52
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429725\"
53
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429724\"
54
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429688\"
55
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429709\"
56
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429699\"
57
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429700\"
58
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429695\"
59
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429691\"
60
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2424669\"
61
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429711\"
62
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429710\"
63
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429694\"
64
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429706\"
65
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429705\"
66
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429707\"
67
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429690\"
68
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429689\"
69
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429713\"
70
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429714\"
71
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429715\"
72
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429696\"
73
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429697\"
74
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429692\"
75
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429703\"
76
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429704\"
77
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429701\"
78
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2338495\"
79
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429723\"
80
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2319350\"
81
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2338303\"
82
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429718\"
83
+ />\n\r\n </rdf:Seq>\r\n </items>\r\n </channel>\r\n <item rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429716\">\n<title>Childhood
84
+ Obesity</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429716</link>\r\n<description>&lt;span
85
+ class=\"paragraphSection\"&gt;&lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429716</dc:identifier>\r\n<dc:creator>Thompson
86
+ AE.</dc:creator>\n<dc:publisher>American Medical Association</dc:publisher>\n<prism:PublicationName>JAMA
87
+ The Journal of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
88
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
89
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429716\"><b>Childhood
90
+ Obesity</b></A><br />Thompson AE. <br /><i>JAMA The Journal of the American
91
+ Medical Association, Vol. , No. (2015) pp. - </i><br />&lt;span class=\"paragraphSection\"&gt;&lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n<item
92
+ rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429719\">\n<title>JAMA</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429719</link>\r\n<description>&lt;br&gt;\nArticle
93
+ URL: http://jama.jamanetwork.com/article.aspx?articleID=2429719&lt;br&gt;\nCitation:
94
+ \ (2015) &lt;br&gt;\nPublication Date: Tue, 25 Aug 2015 00:00:00 GMT&lt;br&gt;\nJournal:
95
+ JAMA The Journal of the American Medical Association</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429719</dc:identifier>\r\n<dc:publisher>American
96
+ Medical Association</dc:publisher>\n<prism:PublicationName>JAMA The Journal
97
+ of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
98
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
99
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429719\"><b>JAMA</b></A><br
100
+ /> <br /><i>JAMA The Journal of the American Medical Association, Vol. , No.
101
+ \ (2015) pp. - </i><br />\nArticle URL: http://jama.jamanetwork.com/article.aspx?articleID=2429719\nCitation:
102
+ \ (2015) \nPublication Date: Tue, 25 Aug 2015 00:00:00 GMT\nJournal: JAMA
103
+ The Journal of the American Medical Association</p>]]></content:encoded>\r\n</item>\n<item
104
+ rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429717\">\n<title>Knowing</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429717</link>\r\n<description>&lt;span
105
+ class=\"paragraphSection\"&gt;Streaks of blue above the treetopsand brightening
106
+ white cloudsbeneath the heavier still windless graysin this tilt to longer
107
+ light already under waytogether with a shift of knowingstirred as endless
108
+ colorin this window patch of sky.And in my lungs a space of knowing named
109
+ at last,which like the changed sky, forever changing,subtle as the light of
110
+ so much more to know remaining.&lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429717</dc:identifier>\r\n<dc:creator>Halberstadt
111
+ C.</dc:creator>\n<dc:publisher>American Medical Association</dc:publisher>\n<prism:PublicationName>JAMA
112
+ The Journal of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
113
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
114
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429717\"><b>Knowing</b></A><br
115
+ />Halberstadt C. <br /><i>JAMA The Journal of the American Medical Association,
116
+ Vol. , No. (2015) pp. - </i><br />&lt;span class=\"paragraphSection\"&gt;Streaks
117
+ of blue above the treetopsand brightening white cloudsbeneath the heavier
118
+ still windless graysin this tilt to longer light already under waytogether
119
+ with a shift of knowingstirred as endless colorin this window patch of sky.And
120
+ in my lungs a space of knowing named at last,which like the changed sky, forever
121
+ changing,subtle as the light of so much more to know remaining.&lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n<item
122
+ rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429702\">\n<title>The
123
+ House: Its Unique Problems in Hygiene</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429702</link>\r\n<description>&lt;span
124
+ class=\"paragraphSection\"&gt;A house erected in accord with modern science
125
+ and the builder&#8217;s art must satisfy a few apparently simple needs. These
126
+ have been cleverly summarized in the following words: protection from the
127
+ elements, from cold and heat, from rain and snow and damp, from intruders
128
+ who might interfere with the family safety or possessions; water at hand;
129
+ some way of getting rid of waste; space for the family, for all their occupations
130
+ and belongings; room for a guest: these were sought by even the cave dwellers.
131
+ And we have not passed beyond these simple needs. Our enemies are of a different
132
+ kind, but the daily paper shows that we must pay for safety locks; and while
133
+ wild animals no longer prowl about, we find it almost impossible to keep out
134
+ rats and mice and harmful insects. The &#8220;house&#8221; fly is now called
135
+ a &#8220;typhoid&#8221; fly, and not permitted even as a casual visitor. To
136
+ all these needs we have added what the cave man did not seek for, since his
137
+ life was largely out of doors. We must have air and sun within doors. Doctors
138
+ are now talking about house diseases. Tuberculosis is one of these, and the
139
+ fight against it must be made, in part, just here. It is for sun and air that
140
+ we have to pay large rents in town; and it is partly to secure these in our
141
+ large dwellings that tenement-house commissions exist, to protect those who
142
+ cannot protect themselves. Then, too, there must be protection against fire,
143
+ not only by the fire department but also in the house itself. Modern nerves,
144
+ moreover, demand quiet. We may want our own phonograph, but we do not care
145
+ to hear our neighbor&#8217;s, and walls and floors must be built to keep out
146
+ sounds. We call these simple needs. They would seem to be human rights; but
147
+ even now, in this twentieth century, how many houses rank 100 per cent. in
148
+ all these: in warmth and coolness at proper seasons; perfect dryness, ventilation
149
+ and lighting; safety from fire and intruders; and room for each member of
150
+ the family to be by himself, and to keep an open door to guests&#39; Yet,
151
+ we cannot be as well or as happy or as useful as we should, until these are
152
+ achieved.&lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429702</dc:identifier>\r\n<dc:publisher>American
153
+ Medical Association</dc:publisher>\n<prism:PublicationName>JAMA The Journal
154
+ of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
155
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
156
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429702\"><b>The
157
+ House: Its Unique Problems in Hygiene</b></A><br /> <br /><i>JAMA The Journal
158
+ of the American Medical Association, Vol. , No. (2015) pp. - </i><br />&lt;span
159
+ class=\"paragraphSection\"&gt;A house erected in accord with modern science
160
+ and the builder&#8217;s art must satisfy a few apparently simple needs. These
161
+ have been cleverly summarized in the following words: protection from the
162
+ elements, from cold and heat, from rain and snow and damp, from intruders
163
+ who might interfere with the family safety or possessions; water at hand;
164
+ some way of getting rid of waste; space for the family, for all their occupations
165
+ and belongings; room for a guest: these were sought by even the cave dwellers.
166
+ And we have not passed beyond these simple needs. Our enemies are of a different
167
+ kind, but the daily paper shows that we must pay for safety locks; and while
168
+ wild animals no longer prowl about, we find it almost impossible to keep out
169
+ rats and mice and harmful insects. The &#8220;house&#8221; fly is now called
170
+ a &#8220;typhoid&#8221; fly, and not permitted even as a casual visitor. To
171
+ all these needs we have added what the cave man did not seek for, since his
172
+ life was largely out of doors. We must have air and sun within doors. Doctors
173
+ are now talking about house diseases. Tuberculosis is one of these, and the
174
+ fight against it must be made, in part, just here. It is for sun and air that
175
+ we have to pay large rents in town; and it is partly to secure these in our
176
+ large dwellings that tenement-house commissions exist, to protect those who
177
+ cannot protect themselves. Then, too, there must be protection against fire,
178
+ not only by the fire department but also in the house itself. Modern nerves,
179
+ moreover, demand quiet. We may want our own phonograph, but we do not care
180
+ to hear our neighbor&#8217;s, and walls and floors must be built to keep out
181
+ sounds. We call these simple needs. They would seem to be human rights; but
182
+ even now, in this twentieth century, how many houses rank 100 per cent. in
183
+ all these: in warmth and coolness at proper seasons; perfect dryness, ventilation
184
+ and lighting; safety from fire and intruders; and room for each member of
185
+ the family to be by himself, and to keep an open door to guests&#39; Yet,
186
+ we cannot be as well or as happy or as useful as we should, until these are
187
+ achieved.&lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n<item rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429693\">\n<title>Next-Generation
188
+ Sequencing to Detect Minimal Residual Disease in AML</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429693</link>\r\n<description>&lt;span
189
+ class=\"paragraphSection\"&gt;Acute myeloid leukemia (AML) represents a heterogeneous
190
+ disease, both with respect to molecular pathogenesis and clinical outcome.
191
+ Although dose-intensive chemotherapy and allogeneic stem cell transplantation
192
+ have improved outcomes in AML, there remains significant heterogeneity in
193
+ clinical outcome such that approximately 20% of patients are cured with existing
194
+ therapies, 20% have therapy-refractory disease from the time of diagnosis,
195
+ and 50% relapse and die from refractory disease after an initial response
196
+ to leukemia therapy. The challenge is how to best determine prognosis and
197
+ identify which patients will have a substantive chance of cure, and which
198
+ patients will likely relapse or present with refractory disease. Current standard
199
+ of care uses clinical, cytogenetic, and molecular factors for risk stratification;
200
+ however, there remains a pressing need for better approaches to prognostication
201
+ in AML.&lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429693</dc:identifier>\r\n<dc:creator>Pastore
202
+ F</dc:creator>\n<dc:creator>Levine RL.</dc:creator>\n<dc:publisher>American
203
+ Medical Association</dc:publisher>\n<prism:PublicationName>JAMA The Journal
204
+ of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
205
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
206
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429693\"><b>Next-Generation
207
+ Sequencing to Detect Minimal Residual Disease in AML</b></A><br />Pastore
208
+ F Levine RL.<br /><i>JAMA The Journal of the American Medical Association,
209
+ Vol. , No. (2015) pp. - </i><br />&lt;span class=\"paragraphSection\"&gt;Acute
210
+ myeloid leukemia (AML) represents a heterogeneous disease, both with respect
211
+ to molecular pathogenesis and clinical outcome. Although dose-intensive chemotherapy
212
+ and allogeneic stem cell transplantation have improved outcomes in AML, there
213
+ remains significant heterogeneity in clinical outcome such that approximately
214
+ 20% of patients are cured with existing therapies, 20% have therapy-refractory
215
+ disease from the time of diagnosis, and 50% relapse and die from refractory
216
+ disease after an initial response to leukemia therapy. The challenge is how
217
+ to best determine prognosis and identify which patients will have a substantive
218
+ chance of cure, and which patients will likely relapse or present with refractory
219
+ disease. Current standard of care uses clinical, cytogenetic, and molecular
220
+ factors for risk stratification; however, there remains a pressing need for
221
+ better approaches to prognostication in AML.&lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n<item
222
+ rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429712\">\n<title>Activity
223
+ Intervention vs Health Education in Sedentary Older Adults</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429712</link>\r\n<description>&lt;span
224
+ class=\"paragraphSection\"&gt;This randomized trial assessed the effects of
225
+ a 24-month physical activity program on cognitive function, mild cognitive
226
+ impairment, and dementia compared with a health education program in sedentary
227
+ adults aged 70 to 89 years.&lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429712</dc:identifier>\r\n<dc:creator>Sink
228
+ KM</dc:creator>\n<dc:creator>Espeland MA</dc:creator>\n<dc:creator>Castro
229
+ CM</dc:creator>\n<dc:creator>et al.</dc:creator>\n<dc:publisher>American Medical
230
+ Association</dc:publisher>\n<prism:PublicationName>JAMA The Journal of the
231
+ American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
232
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
233
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429712\"><b>Activity
234
+ Intervention vs Health Education in Sedentary Older Adults</b></A><br />Sink
235
+ KM Espeland MA, Castro CM, et al.<br /><i>JAMA The Journal of the American
236
+ Medical Association, Vol. , No. (2015) pp. - </i><br />&lt;span class=\"paragraphSection\"&gt;This
237
+ randomized trial assessed the effects of a 24-month physical activity program
238
+ on cognitive function, mild cognitive impairment, and dementia compared with
239
+ a health education program in sedentary adults aged 70 to 89 years.&lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n<item
240
+ rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429698\">\n<title>Recommendations
241
+ to Improve Cardiac Arrest Survival</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429698</link>\r\n<description>&lt;span
242
+ class=\"paragraphSection\"&gt;About 600&#8239;000 people in the United States
243
+ experience cardiac arrest each year, and the National Academy of Medicine
244
+ (NAM) recently released a report titled &#8220;Strategies to Improve Cardiac
245
+ Arrest Survival: A Time to Act&#8221; that details cardiac arrest outcomes
246
+ in the United States and provides recommendations for increasing cardiac arrest
247
+ survival rates (&lt;a href=\"http://bit.ly/1HSyLOQ\"&gt;http://bit.ly/1HSyLOQ&lt;/a&gt;).
248
+ The NAM convened a committee of experts to conduct the study, sponsored by
249
+ the American Heart Association, American Red Cross, American College of Cardiology,
250
+ Centers for Disease Control and Prevention, National Institutes of Health,
251
+ and US Department of Veterans Affairs. According to the report, current survival
252
+ rates are less than 6% for individuals who experience cardiac arrest outside
253
+ of the hospital and less than 24% for patients who experience cardiac arrest
254
+ while hospitalized.&lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429698</dc:identifier>\r\n<dc:creator>Jacob
255
+ JA.</dc:creator>\n<dc:publisher>American Medical Association</dc:publisher>\n<prism:PublicationName>JAMA
256
+ The Journal of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
257
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
258
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429698\"><b>Recommendations
259
+ to Improve Cardiac Arrest Survival</b></A><br />Jacob JA. <br /><i>JAMA The
260
+ Journal of the American Medical Association, Vol. , No. (2015) pp. - </i><br
261
+ />&lt;span class=\"paragraphSection\"&gt;About 600&#8239;000 people in the
262
+ United States experience cardiac arrest each year, and the National Academy
263
+ of Medicine (NAM) recently released a report titled &#8220;Strategies to Improve
264
+ Cardiac Arrest Survival: A Time to Act&#8221; that details cardiac arrest
265
+ outcomes in the United States and provides recommendations for increasing
266
+ cardiac arrest survival rates (&lt;a href=\"http://bit.ly/1HSyLOQ\"&gt;http://bit.ly/1HSyLOQ&lt;/a&gt;).
267
+ The NAM convened a committee of experts to conduct the study, sponsored by
268
+ the American Heart Association, American Red Cross, American College of Cardiology,
269
+ Centers for Disease Control and Prevention, National Institutes of Health,
270
+ and US Department of Veterans Affairs. According to the report, current survival
271
+ rates are less than 6% for individuals who experience cardiac arrest outside
272
+ of the hospital and less than 24% for patients who experience cardiac arrest
273
+ while hospitalized.&lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n<item
274
+ rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429725\">\n<title>Health
275
+ Advice Needed to Cut US Sodium Intake</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429725</link>\r\n<description>&lt;span
276
+ class=\"paragraphSection\"&gt;About half of nearly 200&#8239;000 US adults
277
+ reported in a recent survey that they&#8217;re watching their salt intake
278
+ or reducing it, but only 1 in 5 said a health professional advised them to
279
+ cut back. The data are from the 2013 Behavioral Risk Factor Surveillance System
280
+ telephone survey, which for the first time has provided state-level estimates
281
+ of sodium intake among the general population.&lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429725</dc:identifier>\r\n<dc:publisher>American
282
+ Medical Association</dc:publisher>\n<prism:PublicationName>JAMA The Journal
283
+ of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
284
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
285
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429725\"><b>Health
286
+ Advice Needed to Cut US Sodium Intake</b></A><br /> <br /><i>JAMA The Journal
287
+ of the American Medical Association, Vol. , No. (2015) pp. - </i><br />&lt;span
288
+ class=\"paragraphSection\"&gt;About half of nearly 200&#8239;000 US adults
289
+ reported in a recent survey that they&#8217;re watching their salt intake
290
+ or reducing it, but only 1 in 5 said a health professional advised them to
291
+ cut back. The data are from the 2013 Behavioral Risk Factor Surveillance System
292
+ telephone survey, which for the first time has provided state-level estimates
293
+ of sodium intake among the general population.&lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n<item
294
+ rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429724\">\n<title>Rapid
295
+ US Response to Ebola Threat</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429724</link>\r\n<description>&lt;span
296
+ class=\"paragraphSection\"&gt;More than 10&#8239;000 US residents were monitored
297
+ for potential Ebola virus exposure from November 2014 to March 2015 after
298
+ the CDC issued guidance on preventing transmission of the virus in the United
299
+ States, according to a recent report.&lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429724</dc:identifier>\r\n<dc:publisher>American
300
+ Medical Association</dc:publisher>\n<prism:PublicationName>JAMA The Journal
301
+ of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
302
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
303
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429724\"><b>Rapid
304
+ US Response to Ebola Threat</b></A><br /> <br /><i>JAMA The Journal of the
305
+ American Medical Association, Vol. , No. (2015) pp. - </i><br />&lt;span
306
+ class=\"paragraphSection\"&gt;More than 10&#8239;000 US residents were monitored
307
+ for potential Ebola virus exposure from November 2014 to March 2015 after
308
+ the CDC issued guidance on preventing transmission of the virus in the United
309
+ States, according to a recent report.&lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n<item
310
+ rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429688\">\n<title>Mahabalipooram</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429688</link>\r\n<description>&lt;span
311
+ class=\"paragraphSection\"&gt;The extraordinary life of Edward Lear (1812-1888)
312
+ seems to continue in spirit across space and time from Victorian England to
313
+ the present-day world, conveyed in his captivating works. It may be amusing
314
+ to consider that the same person who concocted the whimsical poem &#8220;The
315
+ Owl and the Pussy-cat&#8221; also gave art lessons to the Queen. Ornithological
316
+ illustrations were included in his early oeuvre, with his later work featuring
317
+ landscapes emanating the allure of faraway lands. &lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429688</dc:identifier>\r\n<dc:creator>Smith
318
+ JM.</dc:creator>\n<dc:publisher>American Medical Association</dc:publisher>\n<prism:PublicationName>JAMA
319
+ The Journal of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
320
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
321
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429688\"><b>Mahabalipooram</b></A><br
322
+ />Smith JM. <br /><i>JAMA The Journal of the American Medical Association,
323
+ Vol. , No. (2015) pp. - </i><br />&lt;span class=\"paragraphSection\"&gt;The
324
+ extraordinary life of Edward Lear (1812-1888) seems to continue in spirit
325
+ across space and time from Victorian England to the present-day world, conveyed
326
+ in his captivating works. It may be amusing to consider that the same person
327
+ who concocted the whimsical poem &#8220;The Owl and the Pussy-cat&#8221; also
328
+ gave art lessons to the Queen. Ornithological illustrations were included
329
+ in his early oeuvre, with his later work featuring landscapes emanating the
330
+ allure of faraway lands. &lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n<item
331
+ rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429709\">\n<title>Diabetes
332
+ Remission After Bariatric Surgery</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429709</link>\r\n<description>&lt;span
333
+ class=\"paragraphSection\"&gt;Obese individuals with type 2 diabetes mellitus
334
+ experienced a remission of their diabetes after bariatric surgery followed
335
+ by 2 years of lifestyle weight loss intervention, according to a recent randomized
336
+ clinical trial. Those who had 3 years of lifestyle modification alone&#8212;1
337
+ year of intensive weight loss counseling followed by 2 years of twice-monthly
338
+ sessions focused on weight loss strategies&#8212;saw no remission of their
339
+ diabetes. The study provided important data on the surgical treatment of individuals
340
+ with class I obesity (body mass index of 30 to &lt;35), who have previously
341
+ been excluded from bariatric surgical trials. The trial also assessed type
342
+ 2 diabetes remission among individuals who received laparoscopic adjustable
343
+ gastric banding (LABG), a reversible and low-risk procedure that may be a
344
+ better surgical alternative for those with lower body mass index (Courcoulas
345
+ AP et al. &lt;span style=\"font-style:italic;\"&gt;JAMA Surg&lt;/span&gt;.
346
+ doi:&lt;a href=\"http://jamanetwork.com/article.aspx&#39;doi=10.1001/jamasurg.2015.1534\"&gt;10.1001/jamasurg.2015.1534&lt;/a&gt;
347
+ [published online July 1, 2015]).&lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429709</dc:identifier>\r\n<dc:creator>Slomski
348
+ A.</dc:creator>\n<dc:publisher>American Medical Association</dc:publisher>\n<prism:PublicationName>JAMA
349
+ The Journal of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
350
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
351
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429709\"><b>Diabetes
352
+ Remission After Bariatric Surgery</b></A><br />Slomski A. <br /><i>JAMA The
353
+ Journal of the American Medical Association, Vol. , No. (2015) pp. - </i><br
354
+ />&lt;span class=\"paragraphSection\"&gt;Obese individuals with type 2 diabetes
355
+ mellitus experienced a remission of their diabetes after bariatric surgery
356
+ followed by 2 years of lifestyle weight loss intervention, according to a
357
+ recent randomized clinical trial. Those who had 3 years of lifestyle modification
358
+ alone&#8212;1 year of intensive weight loss counseling followed by 2 years
359
+ of twice-monthly sessions focused on weight loss strategies&#8212;saw no remission
360
+ of their diabetes. The study provided important data on the surgical treatment
361
+ of individuals with class I obesity (body mass index of 30 to &lt;35), who
362
+ have previously been excluded from bariatric surgical trials. The trial also
363
+ assessed type 2 diabetes remission among individuals who received laparoscopic
364
+ adjustable gastric banding (LABG), a reversible and low-risk procedure that
365
+ may be a better surgical alternative for those with lower body mass index
366
+ (Courcoulas AP et al. &lt;span style=\"font-style:italic;\"&gt;JAMA Surg&lt;/span&gt;.
367
+ doi:&lt;a href=\"http://jamanetwork.com/article.aspx&#39;doi=10.1001/jamasurg.2015.1534\"&gt;10.1001/jamasurg.2015.1534&lt;/a&gt;
368
+ [published online July 1, 2015]).&lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n<item
369
+ rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429699\">\n<title>CMS
370
+ Proposes Payment for Advance Care Planning Discussions</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429699</link>\r\n<description>&lt;span
371
+ class=\"paragraphSection\"&gt;The Centers for Medicare &amp; Medicaid Services
372
+ (CMS) is seeking comment on a proposal to add separate payment rates and codes
373
+ for advance care planning conversations between Medicare beneficiaries and
374
+ physicians or other health care professionals paid under the Medicare Physician
375
+ Fee Schedule. Such discussions may cover, for example, information on treatment
376
+ options, advance directives, and forms patients need to complete to express
377
+ their wishes for end-of-life care. The proposal to offer paid benefit for
378
+ an initial 30-minute session on advance care planning and additional discussions
379
+ would &#8220;better enable seniors and other Medicare beneficiaries to make
380
+ important decisions that give them control over the type of care they receive
381
+ and when they receive it,&#8221; stated a CMS fact sheet (&lt;a href=\"http://go.cms.gov/1KR7miD\"&gt;http://go.cms.gov/1KR7miD&lt;/a&gt;).&lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429699</dc:identifier>\r\n<dc:creator>Jacob
382
+ JA.</dc:creator>\n<dc:publisher>American Medical Association</dc:publisher>\n<prism:PublicationName>JAMA
383
+ The Journal of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
384
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
385
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429699\"><b>CMS
386
+ Proposes Payment for Advance Care Planning Discussions</b></A><br />Jacob
387
+ JA. <br /><i>JAMA The Journal of the American Medical Association, Vol. ,
388
+ No. (2015) pp. - </i><br />&lt;span class=\"paragraphSection\"&gt;The Centers
389
+ for Medicare &amp; Medicaid Services (CMS) is seeking comment on a proposal
390
+ to add separate payment rates and codes for advance care planning conversations
391
+ between Medicare beneficiaries and physicians or other health care professionals
392
+ paid under the Medicare Physician Fee Schedule. Such discussions may cover,
393
+ for example, information on treatment options, advance directives, and forms
394
+ patients need to complete to express their wishes for end-of-life care. The
395
+ proposal to offer paid benefit for an initial 30-minute session on advance
396
+ care planning and additional discussions would &#8220;better enable seniors
397
+ and other Medicare beneficiaries to make important decisions that give them
398
+ control over the type of care they receive and when they receive it,&#8221;
399
+ stated a CMS fact sheet (&lt;a href=\"http://go.cms.gov/1KR7miD\"&gt;http://go.cms.gov/1KR7miD&lt;/a&gt;).&lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n<item
400
+ rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429700\">\n<title>HHS
401
+ Establishes Training and Education Center for Ebola</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429700</link>\r\n<description>&lt;span
402
+ class=\"paragraphSection\"&gt;The Department of Health and Human Service (HHS)
403
+ has allocated $12 million in funds over the next 5 years for a new National
404
+ Ebola Training and Education Center (&lt;a href=\"http://1.usa.gov/1dxrLug\"&gt;http://1.usa.gov/1dxrLug&lt;/a&gt;).
405
+ The Center&#8217;s co-leaders&#8212;Emory University in Atlanta, University
406
+ of Nebraska Medical Center in Omaha, and Bellevue Hospital Center in New York
407
+ City&#8212;will receive the funding to develop and teach courses in caring
408
+ for patients with Ebola and other serious infectious diseases based on evidence-based
409
+ best practices. The training will be offered to state health departments and
410
+ health care facilities.&lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429700</dc:identifier>\r\n<dc:creator>Jacob
411
+ JA.</dc:creator>\n<dc:publisher>American Medical Association</dc:publisher>\n<prism:PublicationName>JAMA
412
+ The Journal of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
413
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
414
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429700\"><b>HHS
415
+ Establishes Training and Education Center for Ebola</b></A><br />Jacob JA.
416
+ <br /><i>JAMA The Journal of the American Medical Association, Vol. , No.
417
+ \ (2015) pp. - </i><br />&lt;span class=\"paragraphSection\"&gt;The Department
418
+ of Health and Human Service (HHS) has allocated $12 million in funds over
419
+ the next 5 years for a new National Ebola Training and Education Center (&lt;a
420
+ href=\"http://1.usa.gov/1dxrLug\"&gt;http://1.usa.gov/1dxrLug&lt;/a&gt;).
421
+ The Center&#8217;s co-leaders&#8212;Emory University in Atlanta, University
422
+ of Nebraska Medical Center in Omaha, and Bellevue Hospital Center in New York
423
+ City&#8212;will receive the funding to develop and teach courses in caring
424
+ for patients with Ebola and other serious infectious diseases based on evidence-based
425
+ best practices. The training will be offered to state health departments and
426
+ health care facilities.&lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n<item
427
+ rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429695\">\n<title>Pediatric
428
+ Pulseless Arrest With &#8220;Nonshockable&#8221; Rhythm</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429695</link>\r\n<description>&lt;span
429
+ class=\"paragraphSection\"&gt;In this issue of &lt;span style=\"font-style:italic;\"&gt;JAMA&lt;/span&gt;,
430
+ Andersen et al report findings from their observational study based on data
431
+ from a national registry of 15&#8239;959 pediatric (&lt;18 years) in-hospital
432
+ cardiac arrests from 2000 to 2014, which included 1558 children (9.8%) who
433
+ received at least 1 dose of epinephrine for nonshockable rhythms (ie, pulseless
434
+ electrical activity or asystole) during cardiopulmonary resuscitation (CPR).
435
+ Among these children (median age, 9 months), 50% received epinephrine during
436
+ the same whole minute as the patient lost their pulse or the next whole minute;
437
+ only 15% received the first dose of epinephrine after 5 minutes of CPR. In
438
+ children receiving epinephrine for nonshockable rhythms, the authors found
439
+ that each minute of delay in epinephrine administration was associated with
440
+ adverse outcomes (ie, lower risk of return of spontaneous circulation [ROSC],
441
+ survival at 24 hours, and discharge from hospital with favorable outcome).&lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429695</dc:identifier>\r\n<dc:creator>Tasker
442
+ RC</dc:creator>\n<dc:creator>Randolph AG.</dc:creator>\n<dc:publisher>American
443
+ Medical Association</dc:publisher>\n<prism:PublicationName>JAMA The Journal
444
+ of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
445
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
446
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429695\"><b>Pediatric
447
+ Pulseless Arrest With &#8220;Nonshockable&#8221; Rhythm</b></A><br />Tasker
448
+ RC Randolph AG.<br /><i>JAMA The Journal of the American Medical Association,
449
+ Vol. , No. (2015) pp. - </i><br />&lt;span class=\"paragraphSection\"&gt;In
450
+ this issue of &lt;span style=\"font-style:italic;\"&gt;JAMA&lt;/span&gt;,
451
+ Andersen et al report findings from their observational study based on data
452
+ from a national registry of 15&#8239;959 pediatric (&lt;18 years) in-hospital
453
+ cardiac arrests from 2000 to 2014, which included 1558 children (9.8%) who
454
+ received at least 1 dose of epinephrine for nonshockable rhythms (ie, pulseless
455
+ electrical activity or asystole) during cardiopulmonary resuscitation (CPR).
456
+ Among these children (median age, 9 months), 50% received epinephrine during
457
+ the same whole minute as the patient lost their pulse or the next whole minute;
458
+ only 15% received the first dose of epinephrine after 5 minutes of CPR. In
459
+ children receiving epinephrine for nonshockable rhythms, the authors found
460
+ that each minute of delay in epinephrine administration was associated with
461
+ adverse outcomes (ie, lower risk of return of spontaneous circulation [ROSC],
462
+ survival at 24 hours, and discharge from hospital with favorable outcome).&lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n<item
463
+ rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429691\">\n<title>Lines
464
+ Omitted From Table</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429691</link>\r\n<description>&lt;span
465
+ class=\"paragraphSection\"&gt;In the Original Investigation entitled &#8220;Mortality,
466
+ Hospitalizations, and Expenditures for the Medicare Population Aged 65 Years
467
+ or Older, 1999-2013&#8221; published in the July 28, 2015, issue of &lt;span
468
+ style=\"font-style:italic;\"&gt;JAMA&lt;/span&gt;, the last 2 rows of Table
469
+ 2 (Expired and Others for 2007-2013) were inadvertently omitted. This article
470
+ was corrected online.&lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429691</dc:identifier>\r\n<dc:publisher>American
471
+ Medical Association</dc:publisher>\n<prism:PublicationName>JAMA The Journal
472
+ of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
473
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
474
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429691\"><b>Lines
475
+ Omitted From Table</b></A><br /> <br /><i>JAMA The Journal of the American
476
+ Medical Association, Vol. , No. (2015) pp. - </i><br />&lt;span class=\"paragraphSection\"&gt;In
477
+ the Original Investigation entitled &#8220;Mortality, Hospitalizations, and
478
+ Expenditures for the Medicare Population Aged 65 Years or Older, 1999-2013&#8221;
479
+ published in the July 28, 2015, issue of &lt;span style=\"font-style:italic;\"&gt;JAMA&lt;/span&gt;,
480
+ the last 2 rows of Table 2 (Expired and Others for 2007-2013) were inadvertently
481
+ omitted. This article was corrected online.&lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n<item
482
+ rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2424669\">\n<title>Safety
483
+ and Fairness in the Right-to-Try</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2424669</link>\r\n<description>&lt;span
484
+ class=\"paragraphSection\"&gt;This Medical News and Perspectives article discusses
485
+ issues surrounding Right-to-Try laws that allow patients with terminal illness
486
+ to petition for access to investigational drugs and therapies.&lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2424669</dc:identifier>\r\n<dc:creator>Jacob
487
+ JA.</dc:creator>\n<dc:publisher>American Medical Association</dc:publisher>\n<prism:PublicationName>JAMA
488
+ The Journal of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
489
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
490
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2424669\"><b>Safety
491
+ and Fairness in the Right-to-Try</b></A><br />Jacob JA. <br /><i>JAMA The
492
+ Journal of the American Medical Association, Vol. , No. (2015) pp. - </i><br
493
+ />&lt;span class=\"paragraphSection\"&gt;This Medical News and Perspectives
494
+ article discusses issues surrounding Right-to-Try laws that allow patients
495
+ with terminal illness to petition for access to investigational drugs and
496
+ therapies.&lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n<item rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429711\">\n<title>Bridging
497
+ Anticoagulation Offers No Benefit</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429711</link>\r\n<description>&lt;span
498
+ class=\"paragraphSection\"&gt;A recent trial found that among patients with
499
+ atrial fibrillation (AF) who stopped taking warfarin before undergoing an
500
+ elective surgery or invasive procedure, forgoing bridging anticoagulation
501
+ was noninferior to perioperative bridging with low-molecular-weight heparin
502
+ to prevent arterial thromboembolism. Bridging also nearly tripled the risk
503
+ of major bleeding without providing benefit in preventing myocardial infarction,
504
+ venous thromboembolism, or death when compared with no bridging (Douketis
505
+ JD et al. &lt;span style=\"font-style:italic;\"&gt;N Engl J Med&lt;/span&gt;.
506
+ doi:&lt;a href=\"http://dx.doi.org/10.1056/NEJMoa1501035\"&gt;10.1056/NEJMoa1501035&lt;/a&gt;
507
+ [published online June 22, 2015]).&lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429711</dc:identifier>\r\n<dc:creator>Slomski
508
+ A.</dc:creator>\n<dc:publisher>American Medical Association</dc:publisher>\n<prism:PublicationName>JAMA
509
+ The Journal of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
510
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
511
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429711\"><b>Bridging
512
+ Anticoagulation Offers No Benefit</b></A><br />Slomski A. <br /><i>JAMA The
513
+ Journal of the American Medical Association, Vol. , No. (2015) pp. - </i><br
514
+ />&lt;span class=\"paragraphSection\"&gt;A recent trial found that among patients
515
+ with atrial fibrillation (AF) who stopped taking warfarin before undergoing
516
+ an elective surgery or invasive procedure, forgoing bridging anticoagulation
517
+ was noninferior to perioperative bridging with low-molecular-weight heparin
518
+ to prevent arterial thromboembolism. Bridging also nearly tripled the risk
519
+ of major bleeding without providing benefit in preventing myocardial infarction,
520
+ venous thromboembolism, or death when compared with no bridging (Douketis
521
+ JD et al. &lt;span style=\"font-style:italic;\"&gt;N Engl J Med&lt;/span&gt;.
522
+ doi:&lt;a href=\"http://dx.doi.org/10.1056/NEJMoa1501035\"&gt;10.1056/NEJMoa1501035&lt;/a&gt;
523
+ [published online June 22, 2015]).&lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n<item
524
+ rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429710\">\n<title>Diabetes
525
+ Drug Promotes Weight Loss in Patients</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429710</link>\r\n<description>&lt;span
526
+ class=\"paragraphSection\"&gt;Results from a recent placebo-controlled trial
527
+ suggest liraglutide, a glucagon-like peptide-1 analogue approved to treat
528
+ type 2 diabetes, can help shed body weight and improve glycemic control among
529
+ people who were very overweight or obese&#8212;but not diabetic. The trial,
530
+ consisting of 3731 participants, also found that participants who had taken
531
+ liraglutide had a significantly lower incidence of prediabetes after 56 weeks
532
+ and developed type 2 diabetes at a significantly lower rate compared with
533
+ participants taking placebo (Pi-Sunyer X et al. &lt;span style=\"font-style:italic;\"&gt;N
534
+ Engl J Med&lt;/span&gt;. 2015;373[1]:11-22).&lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429710</dc:identifier>\r\n<dc:creator>Slomski
535
+ A.</dc:creator>\n<dc:publisher>American Medical Association</dc:publisher>\n<prism:PublicationName>JAMA
536
+ The Journal of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
537
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
538
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429710\"><b>Diabetes
539
+ Drug Promotes Weight Loss in Patients</b></A><br />Slomski A. <br /><i>JAMA
540
+ The Journal of the American Medical Association, Vol. , No. (2015) pp. -
541
+ </i><br />&lt;span class=\"paragraphSection\"&gt;Results from a recent placebo-controlled
542
+ trial suggest liraglutide, a glucagon-like peptide-1 analogue approved to
543
+ treat type 2 diabetes, can help shed body weight and improve glycemic control
544
+ among people who were very overweight or obese&#8212;but not diabetic. The
545
+ trial, consisting of 3731 participants, also found that participants who had
546
+ taken liraglutide had a significantly lower incidence of prediabetes after
547
+ 56 weeks and developed type 2 diabetes at a significantly lower rate compared
548
+ with participants taking placebo (Pi-Sunyer X et al. &lt;span style=\"font-style:italic;\"&gt;N
549
+ Engl J Med&lt;/span&gt;. 2015;373[1]:11-22).&lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n<item
550
+ rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429694\">\n<title>Optimizing
551
+ Cognitive Health in Older Individuals</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429694</link>\r\n<description>&lt;span
552
+ class=\"paragraphSection\"&gt;Loss of cognitive function and the development
553
+ of dementia are among the greatest concerns confronting older individuals.
554
+ As populations around the world age, the global prevalence of dementia is
555
+ predicted to increase substantially from an estimated 35.6 million in 2010
556
+ to 65.7 million in 2030, and 115.4 million in 2050. In the United States in
557
+ 1990, Alzheimer disease ranked 25th in terms of disability-adjusted life-years
558
+ lost. In 2010, it ranked 12th, with the greatest median percentage change
559
+ of any of the leading 30 diseases. The burden of mild cognitive impairment
560
+ (MCI) is even larger. Discussions between physicians and patients about strategies
561
+ to prevent cognitive decline and dementia have become commonplace, and there
562
+ is great interest in new evidence of lifestyle modifications that might improve
563
+ cognitive aging and prevent the onset of dementia. These lifestyle modifications
564
+ include exercise, dietary changes, cognitive training (ie, &#8220;brain games&#8221;),
565
+ and multimodal treatments. A meta-analysis of observational studies found
566
+ that the modifiable risk factors that have most consistently been associated
567
+ with a reduced risk of dementia include higher educational attainment, increased
568
+ physical activity, and avoidance of smoking.&lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429694</dc:identifier>\r\n<dc:creator>Gill
569
+ SS</dc:creator>\n<dc:creator>Seitz DP.</dc:creator>\n<dc:publisher>American
570
+ Medical Association</dc:publisher>\n<prism:PublicationName>JAMA The Journal
571
+ of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
572
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
573
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429694\"><b>Optimizing
574
+ Cognitive Health in Older Individuals</b></A><br />Gill SS Seitz DP.<br /><i>JAMA
575
+ The Journal of the American Medical Association, Vol. , No. (2015) pp. -
576
+ </i><br />&lt;span class=\"paragraphSection\"&gt;Loss of cognitive function
577
+ and the development of dementia are among the greatest concerns confronting
578
+ older individuals. As populations around the world age, the global prevalence
579
+ of dementia is predicted to increase substantially from an estimated 35.6
580
+ million in 2010 to 65.7 million in 2030, and 115.4 million in 2050. In the
581
+ United States in 1990, Alzheimer disease ranked 25th in terms of disability-adjusted
582
+ life-years lost. In 2010, it ranked 12th, with the greatest median percentage
583
+ change of any of the leading 30 diseases. The burden of mild cognitive impairment
584
+ (MCI) is even larger. Discussions between physicians and patients about strategies
585
+ to prevent cognitive decline and dementia have become commonplace, and there
586
+ is great interest in new evidence of lifestyle modifications that might improve
587
+ cognitive aging and prevent the onset of dementia. These lifestyle modifications
588
+ include exercise, dietary changes, cognitive training (ie, &#8220;brain games&#8221;),
589
+ and multimodal treatments. A meta-analysis of observational studies found
590
+ that the modifiable risk factors that have most consistently been associated
591
+ with a reduced risk of dementia include higher educational attainment, increased
592
+ physical activity, and avoidance of smoking.&lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n<item
593
+ rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429706\">\n<title>Opioid
594
+ Dependence Treatment in the Emergency Department</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429706</link>\r\n<description>&lt;span
595
+ class=\"paragraphSection\"&gt;&lt;strong&gt;In Reply&lt;/strong&gt; Dr Swartz
596
+ provides an opportunity to discuss the fundamental principles of clinical
597
+ research and opioid dependence treatment that guided our study. Clinical trial
598
+ design involves selecting a primary, clinically important outcome at a point
599
+ in time. Our primary outcome was engagement in treatment at 30 days. We chose
600
+ engagement in treatment as the primary outcome because it is associated with
601
+ decreased criminal activity, HIV transmission, and mortality.&lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429706</dc:identifier>\r\n<dc:creator>Fiellin
602
+ DA</dc:creator>\n<dc:creator>O&amp;#8217;Connor PG, D&amp;#8217;Onofrio G.</dc:creator>\n<dc:publisher>American
603
+ Medical Association</dc:publisher>\n<prism:PublicationName>JAMA The Journal
604
+ of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
605
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
606
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429706\"><b>Opioid
607
+ Dependence Treatment in the Emergency Department</b></A><br />Fiellin DA O&#8217;Connor
608
+ PG, D&#8217;Onofrio G.<br /><i>JAMA The Journal of the American Medical Association,
609
+ Vol. , No. (2015) pp. - </i><br />&lt;span class=\"paragraphSection\"&gt;&lt;strong&gt;In
610
+ Reply&lt;/strong&gt; Dr Swartz provides an opportunity to discuss the fundamental
611
+ principles of clinical research and opioid dependence treatment that guided
612
+ our study. Clinical trial design involves selecting a primary, clinically
613
+ important outcome at a point in time. Our primary outcome was engagement in
614
+ treatment at 30 days. We chose engagement in treatment as the primary outcome
615
+ because it is associated with decreased criminal activity, HIV transmission,
616
+ and mortality.&lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n<item rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429705\">\n<title>Etiologies
617
+ of Tattoo Lesions</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429705</link>\r\n<description>&lt;span
618
+ class=\"paragraphSection\"&gt;&lt;strong&gt;To the Editor&lt;/strong&gt; Dr
619
+ Ayoola and colleagues described a patient with systemic sarcoidosis presenting
620
+ with skin lesions of his tattoos. The authors stated that the differential
621
+ diagnosis of the skin lesions included drug eruptions, T-cell lymphoma, and
622
+ tuberculosis. However, other possibilities should have been considered.&lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429705</dc:identifier>\r\n<dc:creator>Han
623
+ F.</dc:creator>\n<dc:publisher>American Medical Association</dc:publisher>\n<prism:PublicationName>JAMA
624
+ The Journal of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
625
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
626
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429705\"><b>Etiologies
627
+ of Tattoo Lesions</b></A><br />Han F. <br /><i>JAMA The Journal of the American
628
+ Medical Association, Vol. , No. (2015) pp. - </i><br />&lt;span class=\"paragraphSection\"&gt;&lt;strong&gt;To
629
+ the Editor&lt;/strong&gt; Dr Ayoola and colleagues described a patient with
630
+ systemic sarcoidosis presenting with skin lesions of his tattoos. The authors
631
+ stated that the differential diagnosis of the skin lesions included drug eruptions,
632
+ T-cell lymphoma, and tuberculosis. However, other possibilities should have
633
+ been considered.&lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n<item rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429707\">\n<title>Etiologies
634
+ of Tattoo Lesions</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429707</link>\r\n<description>&lt;span
635
+ class=\"paragraphSection\"&gt;&lt;strong&gt;In Reply&lt;/strong&gt; Mr Han
636
+ raises questions about the differential diagnosis of cutaneous manifestations
637
+ of sarcoidosis in tattoos. We included drug eruptions, T-cell lymphoma, and
638
+ tuberculosis as differential diagnoses for our patient with tattoo sarcoidosis.
639
+ One of the most common differential diagnoses is foreign body granuloma. These
640
+ reactions are attributable to the pigment in tattoo ink. Histologically they
641
+ can be differentiated by the presence of foreign bodies. Generally, reactions
642
+ to single pigments are found in foreign body granulomas; if multiple pigments
643
+ are involved, systemic sarcoidosis is more likely.&lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429707</dc:identifier>\r\n<dc:creator>Jamindar
644
+ P</dc:creator>\n<dc:creator>Powner J</dc:creator>\n<dc:creator>Ayoola R.</dc:creator>\n<dc:publisher>American
645
+ Medical Association</dc:publisher>\n<prism:PublicationName>JAMA The Journal
646
+ of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
647
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
648
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429707\"><b>Etiologies
649
+ of Tattoo Lesions</b></A><br />Jamindar P Powner J, Ayoola R.<br /><i>JAMA
650
+ The Journal of the American Medical Association, Vol. , No. (2015) pp. -
651
+ </i><br />&lt;span class=\"paragraphSection\"&gt;&lt;strong&gt;In Reply&lt;/strong&gt;
652
+ Mr Han raises questions about the differential diagnosis of cutaneous manifestations
653
+ of sarcoidosis in tattoos. We included drug eruptions, T-cell lymphoma, and
654
+ tuberculosis as differential diagnoses for our patient with tattoo sarcoidosis.
655
+ One of the most common differential diagnoses is foreign body granuloma. These
656
+ reactions are attributable to the pigment in tattoo ink. Histologically they
657
+ can be differentiated by the presence of foreign bodies. Generally, reactions
658
+ to single pigments are found in foreign body granulomas; if multiple pigments
659
+ are involved, systemic sarcoidosis is more likely.&lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n<item
660
+ rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429690\">\n<title>Incorrect
661
+ Study Name</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429690</link>\r\n<description>&lt;span
662
+ class=\"paragraphSection\"&gt;In the Review Article entitled &#8220;Stroke
663
+ Prevention in Atrial Fibrillation: A Systematic Review&#8221; in the May 19,
664
+ 2015, issue of &lt;span style=\"font-style:italic;\"&gt;JAMA&lt;/span&gt;,
665
+ the ARISTOLE trial was incorrectly expanded. It should have read &#8220;Apixaban
666
+ for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation.&#8221;
667
+ This article was corrected online.&lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429690</dc:identifier>\r\n<dc:publisher>American
668
+ Medical Association</dc:publisher>\n<prism:PublicationName>JAMA The Journal
669
+ of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
670
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
671
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429690\"><b>Incorrect
672
+ Study Name</b></A><br /> <br /><i>JAMA The Journal of the American Medical
673
+ Association, Vol. , No. (2015) pp. - </i><br />&lt;span class=\"paragraphSection\"&gt;In
674
+ the Review Article entitled &#8220;Stroke Prevention in Atrial Fibrillation:
675
+ A Systematic Review&#8221; in the May 19, 2015, issue of &lt;span style=\"font-style:italic;\"&gt;JAMA&lt;/span&gt;,
676
+ the ARISTOLE trial was incorrectly expanded. It should have read &#8220;Apixaban
677
+ for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation.&#8221;
678
+ This article was corrected online.&lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n<item
679
+ rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429689\">\n<title>Incorrect
680
+ Values Reported</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429689</link>\r\n<description>&lt;span
681
+ class=\"paragraphSection\"&gt;In the Original Investigation entitled &#8220;Cannabinoids
682
+ for Medical Use: A Systematic Review and Meta-analysis&#8221; published in
683
+ the June 23/30, 2015, issue of &lt;span style=\"font-style:italic;\"&gt;JAMA&lt;/span&gt;,
684
+ the value for the average reduction in the Ashworth spasticity scale should
685
+ have been reported as &#8220;weighted mean difference, &#8722;0.12 (95% CI,
686
+ &#8722;0.24 to 0.01); 5 trials.&#8221; This article was corrected online.&lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429689</dc:identifier>\r\n<dc:publisher>American
687
+ Medical Association</dc:publisher>\n<prism:PublicationName>JAMA The Journal
688
+ of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
689
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
690
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429689\"><b>Incorrect
691
+ Values Reported</b></A><br /> <br /><i>JAMA The Journal of the American Medical
692
+ Association, Vol. , No. (2015) pp. - </i><br />&lt;span class=\"paragraphSection\"&gt;In
693
+ the Original Investigation entitled &#8220;Cannabinoids for Medical Use: A
694
+ Systematic Review and Meta-analysis&#8221; published in the June 23/30, 2015,
695
+ issue of &lt;span style=\"font-style:italic;\"&gt;JAMA&lt;/span&gt;, the value
696
+ for the average reduction in the Ashworth spasticity scale should have been
697
+ reported as &#8220;weighted mean difference, &#8722;0.12 (95% CI, &#8722;0.24
698
+ to 0.01); 5 trials.&#8221; This article was corrected online.&lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n<item
699
+ rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429713\">\n<title>Effect
700
+ of Nutrient Supplementation on Cognitive Function</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429713</link>\r\n<description>&lt;span
701
+ class=\"paragraphSection\"&gt;This randomized trial reports that among older
702
+ individuals with age-related macular degeneration supplements containing long-chain
703
+ fatty acids and/or lutein and zeaxanthin had no effect on cognitive function.&lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429713</dc:identifier>\r\n<dc:creator>Chew
704
+ EY</dc:creator>\n<dc:creator>Clemons TE, Agr&amp;#243;n E, et al.</dc:creator>\n<dc:publisher>American
705
+ Medical Association</dc:publisher>\n<prism:PublicationName>JAMA The Journal
706
+ of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
707
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
708
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429713\"><b>Effect
709
+ of Nutrient Supplementation on Cognitive Function</b></A><br />Chew EY Clemons
710
+ TE, Agr&#243;n E, et al.<br /><i>JAMA The Journal of the American Medical
711
+ Association, Vol. , No. (2015) pp. - </i><br />&lt;span class=\"paragraphSection\"&gt;This
712
+ randomized trial reports that among older individuals with age-related macular
713
+ degeneration supplements containing long-chain fatty acids and/or lutein and
714
+ zeaxanthin had no effect on cognitive function.&lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n<item
715
+ rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429714\">\n<title>Time
716
+ to Epinephrine After Pediatric In-Hospital Cardiac Arrest</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429714</link>\r\n<description>&lt;span
717
+ class=\"paragraphSection\"&gt;This study uses data for pediatric patients
718
+ from the Get With the Guidelines&#8211;Resuscitation registry to report associations
719
+ between delay in epinephrine and survival and neurological outcome after pediatric
720
+ in-hospital cardiac arrest.&lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429714</dc:identifier>\r\n<dc:creator>Andersen
721
+ LW</dc:creator>\n<dc:creator>Berg KM</dc:creator>\n<dc:creator>Saindon BZ</dc:creator>\n<dc:creator>et
722
+ al.</dc:creator>\n<dc:publisher>American Medical Association</dc:publisher>\n<prism:PublicationName>JAMA
723
+ The Journal of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
724
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
725
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429714\"><b>Time
726
+ to Epinephrine After Pediatric In-Hospital Cardiac Arrest</b></A><br />Andersen
727
+ LW Berg KM, Saindon BZ, et al.<br /><i>JAMA The Journal of the American
728
+ Medical Association, Vol. , No. (2015) pp. - </i><br />&lt;span class=\"paragraphSection\"&gt;This
729
+ study uses data for pediatric patients from the Get With the Guidelines&#8211;Resuscitation
730
+ registry to report associations between delay in epinephrine and survival
731
+ and neurological outcome after pediatric in-hospital cardiac arrest.&lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n<item
732
+ rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429715\">\n<title>Mutation
733
+ Clearance After Chemotherapy and Outcomes in AML</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429715</link>\r\n<description>&lt;span
734
+ class=\"paragraphSection\"&gt;This cohort study investigates clearance patterns
735
+ of somatic mutations in acute myeloid leukemia patients given induction chemotherapy,
736
+ and associations between those patterns and clinical outcomes.&lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429715</dc:identifier>\r\n<dc:creator>Klco
737
+ JM</dc:creator>\n<dc:creator>Miller CA</dc:creator>\n<dc:creator>Griffith
738
+ M</dc:creator>\n<dc:creator>et al.</dc:creator>\n<dc:publisher>American Medical
739
+ Association</dc:publisher>\n<prism:PublicationName>JAMA The Journal of the
740
+ American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
741
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
742
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429715\"><b>Mutation
743
+ Clearance After Chemotherapy and Outcomes in AML</b></A><br />Klco JM Miller
744
+ CA, Griffith M, et al.<br /><i>JAMA The Journal of the American Medical
745
+ Association, Vol. , No. (2015) pp. - </i><br />&lt;span class=\"paragraphSection\"&gt;This
746
+ cohort study investigates clearance patterns of somatic mutations in acute
747
+ myeloid leukemia patients given induction chemotherapy, and associations between
748
+ those patterns and clinical outcomes.&lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n<item
749
+ rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429696\">\n<title>Engaging
750
+ Primary Care Clinicians in Early Obesity Prevention Research</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429696</link>\r\n<description>&lt;span
751
+ class=\"paragraphSection\"&gt;This commentary describes a report published
752
+ in &lt;span style=\"font-style:italic;\"&gt;JAMA Pediatrics&lt;/span&gt; summarizing
753
+ a National Institutes of Health workshop about primary care clinician involvement
754
+ in preventing early childhood obesity.&lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429696</dc:identifier>\r\n<dc:creator>Faith
755
+ MS</dc:creator>\n<dc:creator>Stettler N</dc:creator>\n<dc:creator>Pietrobelli
756
+ A.</dc:creator>\n<dc:publisher>American Medical Association</dc:publisher>\n<prism:PublicationName>JAMA
757
+ The Journal of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
758
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
759
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429696\"><b>Engaging
760
+ Primary Care Clinicians in Early Obesity Prevention Research</b></A><br />Faith
761
+ MS Stettler N, Pietrobelli A.<br /><i>JAMA The Journal of the American Medical
762
+ Association, Vol. , No. (2015) pp. - </i><br />&lt;span class=\"paragraphSection\"&gt;This
763
+ commentary describes a report published in &lt;span style=\"font-style:italic;\"&gt;JAMA
764
+ Pediatrics&lt;/span&gt; summarizing a National Institutes of Health workshop
765
+ about primary care clinician involvement in preventing early childhood obesity.&lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n<item
766
+ rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429697\">\n<title>Prostate
767
+ Cancer Screening</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429697</link>\r\n<description>&lt;span
768
+ class=\"paragraphSection\"&gt;This JAMA Clinical Guidelines Synopsis summarizes
769
+ the US Preventive Services Task Force&#8217;s (2012) and American Urological
770
+ Association&#8217;s (2013) clinical practice guidelines for prostate cancer
771
+ screening.&lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429697</dc:identifier>\r\n<dc:creator>Eggener
772
+ SE</dc:creator>\n<dc:creator>Cifu AS</dc:creator>\n<dc:creator>Nabhan C.</dc:creator>\n<dc:publisher>American
773
+ Medical Association</dc:publisher>\n<prism:PublicationName>JAMA The Journal
774
+ of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
775
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
776
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429697\"><b>Prostate
777
+ Cancer Screening</b></A><br />Eggener SE Cifu AS, Nabhan C.<br /><i>JAMA
778
+ The Journal of the American Medical Association, Vol. , No. (2015) pp. -
779
+ </i><br />&lt;span class=\"paragraphSection\"&gt;This JAMA Clinical Guidelines
780
+ Synopsis summarizes the US Preventive Services Task Force&#8217;s (2012) and
781
+ American Urological Association&#8217;s (2013) clinical practice guidelines
782
+ for prostate cancer screening.&lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n<item
783
+ rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429692\">\n<title>Clinical
784
+ Significance of Positive Antinuclear Antibody Test</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429692</link>\r\n<description>&lt;span
785
+ class=\"paragraphSection\"&gt;A 30-year-old woman with polyarthralgias responsive
786
+ to celecoxib has an ANA titer of 1:80. How do you interpret this test result&#39;&lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429692</dc:identifier>\r\n<dc:creator>Fatemi
787
+ G</dc:creator>\n<dc:creator>Kermani TA.</dc:creator>\n<dc:publisher>American
788
+ Medical Association</dc:publisher>\n<prism:PublicationName>JAMA The Journal
789
+ of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
790
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
791
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429692\"><b>Clinical
792
+ Significance of Positive Antinuclear Antibody Test</b></A><br />Fatemi G Kermani
793
+ TA.<br /><i>JAMA The Journal of the American Medical Association, Vol. , No.
794
+ \ (2015) pp. - </i><br />&lt;span class=\"paragraphSection\"&gt;A 30-year-old
795
+ woman with polyarthralgias responsive to celecoxib has an ANA titer of 1:80.
796
+ How do you interpret this test result&#39;&lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n<item
797
+ rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429703\">\n<title>Military
798
+ Misconduct and Homelessness Among US Veterans, 2001-2012</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429703</link>\r\n<description>&lt;span
799
+ class=\"paragraphSection\"&gt;This study used Veterans Health Administration
800
+ data to investigate the association between misconduct-related separations
801
+ and homelessness among recently returned active-duty US military service members.&lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429703</dc:identifier>\r\n<dc:creator>Gundlapalli
802
+ AV</dc:creator>\n<dc:creator>Fargo JD</dc:creator>\n<dc:creator>Metraux S</dc:creator>\n<dc:creator>et
803
+ al.</dc:creator>\n<dc:publisher>American Medical Association</dc:publisher>\n<prism:PublicationName>JAMA
804
+ The Journal of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
805
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
806
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429703\"><b>Military
807
+ Misconduct and Homelessness Among US Veterans, 2001-2012</b></A><br />Gundlapalli
808
+ AV Fargo JD, Metraux S, et al.<br /><i>JAMA The Journal of the American
809
+ Medical Association, Vol. , No. (2015) pp. - </i><br />&lt;span class=\"paragraphSection\"&gt;This
810
+ study used Veterans Health Administration data to investigate the association
811
+ between misconduct-related separations and homelessness among recently returned
812
+ active-duty US military service members.&lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n<item
813
+ rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429704\">\n<title>Opioid
814
+ Dependence Treatment in the Emergency Department</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429704</link>\r\n<description>&lt;span
815
+ class=\"paragraphSection\"&gt;&lt;strong&gt;To the Editor&lt;/strong&gt; In
816
+ the article about emergency department (ED)&#8211;initiated buprenorphine/naloxone
817
+ treatment for opioid dependence, Dr D&#8217;Onofrio and colleagues omitted
818
+ important information and then focused on the most optimistic outcomes to
819
+ infer a benefit.&lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429704</dc:identifier>\r\n<dc:creator>Swartz
820
+ AW.</dc:creator>\n<dc:publisher>American Medical Association</dc:publisher>\n<prism:PublicationName>JAMA
821
+ The Journal of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
822
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
823
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429704\"><b>Opioid
824
+ Dependence Treatment in the Emergency Department</b></A><br />Swartz AW. <br
825
+ /><i>JAMA The Journal of the American Medical Association, Vol. , No. (2015)
826
+ pp. - </i><br />&lt;span class=\"paragraphSection\"&gt;&lt;strong&gt;To the
827
+ Editor&lt;/strong&gt; In the article about emergency department (ED)&#8211;initiated
828
+ buprenorphine/naloxone treatment for opioid dependence, Dr D&#8217;Onofrio
829
+ and colleagues omitted important information and then focused on the most
830
+ optimistic outcomes to infer a benefit.&lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n<item
831
+ rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429701\">\n<title>Highlights
832
+ for August 25, 2015</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429701</link>\r\n<description>&lt;br&gt;\nArticle
833
+ URL: http://jama.jamanetwork.com/article.aspx?articleID=2429701&lt;br&gt;\nCitation:
834
+ \ (2015) &lt;br&gt;\nPublication Date: Tue, 25 Aug 2015 00:00:00 GMT&lt;br&gt;\nJournal:
835
+ JAMA The Journal of the American Medical Association</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429701</dc:identifier>\r\n<dc:publisher>American
836
+ Medical Association</dc:publisher>\n<prism:PublicationName>JAMA The Journal
837
+ of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
838
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
839
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429701\"><b>Highlights
840
+ for August 25, 2015</b></A><br /> <br /><i>JAMA The Journal of the American
841
+ Medical Association, Vol. , No. (2015) pp. - </i><br />\nArticle URL: http://jama.jamanetwork.com/article.aspx?articleID=2429701\nCitation:
842
+ \ (2015) \nPublication Date: Tue, 25 Aug 2015 00:00:00 GMT\nJournal: JAMA
843
+ The Journal of the American Medical Association</p>]]></content:encoded>\r\n</item>\n<item
844
+ rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2338495\">\n<title>Sexual
845
+ Health in America</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2338495</link>\r\n<description>&lt;span
846
+ class=\"paragraphSection\"&gt;This Viewpoint discusses a framework for improving
847
+ patient care and public sexual health.&lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2338495</dc:identifier>\r\n<dc:creator>Satcher
848
+ D</dc:creator>\n<dc:creator>Hook EW</dc:creator>\n<dc:creator>III</dc:creator>\n<dc:creator>Coleman
849
+ E.</dc:creator>\n<dc:publisher>American Medical Association</dc:publisher>\n<prism:PublicationName>JAMA
850
+ The Journal of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
851
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
852
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2338495\"><b>Sexual
853
+ Health in America</b></A><br />Satcher D Hook EW, III, Coleman E.<br /><i>JAMA
854
+ The Journal of the American Medical Association, Vol. , No. (2015) pp. -
855
+ </i><br />&lt;span class=\"paragraphSection\"&gt;This Viewpoint discusses
856
+ a framework for improving patient care and public sexual health.&lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n<item
857
+ rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429723\">\n<title>Fusing
858
+ Randomized Trials With Big Data</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429723</link>\r\n<description>&lt;span
859
+ class=\"paragraphSection\"&gt;This Viewpoint proposes ways that electronic
860
+ health records and other &#8220;big data&#8221; can be integrated with randomized
861
+ trial designs to leverage the strengths of both for research inferences.&lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429723</dc:identifier>\r\n<dc:creator>Angus
862
+ DC.</dc:creator>\n<dc:publisher>American Medical Association</dc:publisher>\n<prism:PublicationName>JAMA
863
+ The Journal of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
864
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
865
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429723\"><b>Fusing
866
+ Randomized Trials With Big Data</b></A><br />Angus DC. <br /><i>JAMA The Journal
867
+ of the American Medical Association, Vol. , No. (2015) pp. - </i><br />&lt;span
868
+ class=\"paragraphSection\"&gt;This Viewpoint proposes ways that electronic
869
+ health records and other &#8220;big data&#8221; can be integrated with randomized
870
+ trial designs to leverage the strengths of both for research inferences.&lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n<item
871
+ rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2319350\">\n<title>Quality
872
+ Metrics for Physical and Behavioral Health Care Integration</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2319350</link>\r\n<description>&lt;span
873
+ class=\"paragraphSection\"&gt;This Viewpoint discusses developing quality
874
+ metrics in behavioral and general health care to encourage more cost-effective
875
+ care and improve the status quo.&lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2319350</dc:identifier>\r\n<dc:creator>Goldman
876
+ ML</dc:creator>\n<dc:creator>Spaeth-;Rublee B</dc:creator>\n<dc:creator>Pincus
877
+ H.</dc:creator>\n<dc:publisher>American Medical Association</dc:publisher>\n<prism:PublicationName>JAMA
878
+ The Journal of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
879
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
880
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2319350\"><b>Quality
881
+ Metrics for Physical and Behavioral Health Care Integration</b></A><br />Goldman
882
+ ML Spaeth-Rublee B, Pincus H.<br /><i>JAMA The Journal of the American Medical
883
+ Association, Vol. , No. (2015) pp. - </i><br />&lt;span class=\"paragraphSection\"&gt;This
884
+ Viewpoint discusses developing quality metrics in behavioral and general health
885
+ care to encourage more cost-effective care and improve the status quo.&lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n<item
886
+ rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2338303\">\n<title>Middle
887
+ East Respiratory Syndrome: A Global Health Challenge</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2338303</link>\r\n<description>&lt;span
888
+ class=\"paragraphSection\"&gt;This Viewpoint discusses the importance of a
889
+ well-trained and well-prepared health workforce in controlling outbreaks such
890
+ as Middle East respiratory syndrome.&lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2338303</dc:identifier>\r\n<dc:creator>Gostin
891
+ LO</dc:creator>\n<dc:creator>Lucey D.</dc:creator>\n<dc:publisher>American
892
+ Medical Association</dc:publisher>\n<prism:PublicationName>JAMA The Journal
893
+ of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
894
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
895
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2338303\"><b>Middle
896
+ East Respiratory Syndrome: A Global Health Challenge</b></A><br />Gostin LO
897
+ Lucey D.<br /><i>JAMA The Journal of the American Medical Association, Vol.
898
+ , No. (2015) pp. - </i><br />&lt;span class=\"paragraphSection\"&gt;This
899
+ Viewpoint discusses the importance of a well-trained and well-prepared health
900
+ workforce in controlling outbreaks such as Middle East respiratory syndrome.&lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n<item
901
+ rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429718\">\n<title>The
902
+ &#8220;Good Person&#8221; Sign</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429718</link>\r\n<description>&lt;span
903
+ class=\"paragraphSection\"&gt;When I started medical school, I received a
904
+ lot of (mostly unsolicited) advice on various topics, ranging from specialty
905
+ choice to the importance of keeping work-life balance to how to befriend nurses
906
+ in order to get things done. I would listen passively while friends and family
907
+ blathered on about how comfortable their subspecialists&#8217; lifestyles
908
+ were. One recurring theme that I actively paid attention to was how often
909
+ people advised me to avoid becoming &#8220;one of those&#8221; doctors who
910
+ distanced themselves from their patients. I didn&#8217;t quite understand
911
+ why some people could ever view physicians to be uncaring, cold, and callous,
912
+ and why physicians allowed themselves to be perceived as such. Medicine is
913
+ still the noblest of professions, and one would expect altruism as a baseline
914
+ for all who go into the field. Personally, I was able to hold on tightly to
915
+ my humanity and positive attitude throughout the preclinical years of medical
916
+ school without issue. I even received high marks for compassion and empathy
917
+ in our &#8220;doctoring&#8221; courses. At that point in my training I continued
918
+ to feel as though I were above falling victim to the fate of the heartless
919
+ physician. So why, I wondered in my short, unwrinkled, and as yet unblemished
920
+ white coat, were some physicians so detached from their patients&#39; Once
921
+ the clinical years started, I quickly discovered the answer.&lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429718</dc:identifier>\r\n<dc:creator>Dempsey
922
+ TM.</dc:creator>\n<dc:publisher>American Medical Association</dc:publisher>\n<prism:PublicationName>JAMA
923
+ The Journal of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
924
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
925
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429718\"><b>The
926
+ &#8220;Good Person&#8221; Sign</b></A><br />Dempsey TM. <br /><i>JAMA The
927
+ Journal of the American Medical Association, Vol. , No. (2015) pp. - </i><br
928
+ />&lt;span class=\"paragraphSection\"&gt;When I started medical school, I
929
+ received a lot of (mostly unsolicited) advice on various topics, ranging from
930
+ specialty choice to the importance of keeping work-life balance to how to
931
+ befriend nurses in order to get things done. I would listen passively while
932
+ friends and family blathered on about how comfortable their subspecialists&#8217;
933
+ lifestyles were. One recurring theme that I actively paid attention to was
934
+ how often people advised me to avoid becoming &#8220;one of those&#8221; doctors
935
+ who distanced themselves from their patients. I didn&#8217;t quite understand
936
+ why some people could ever view physicians to be uncaring, cold, and callous,
937
+ and why physicians allowed themselves to be perceived as such. Medicine is
938
+ still the noblest of professions, and one would expect altruism as a baseline
939
+ for all who go into the field. Personally, I was able to hold on tightly to
940
+ my humanity and positive attitude throughout the preclinical years of medical
941
+ school without issue. I even received high marks for compassion and empathy
942
+ in our &#8220;doctoring&#8221; courses. At that point in my training I continued
943
+ to feel as though I were above falling victim to the fate of the heartless
944
+ physician. So why, I wondered in my short, unwrinkled, and as yet unblemished
945
+ white coat, were some physicians so detached from their patients&#39; Once
946
+ the clinical years started, I quickly discovered the answer.&lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n\r\n\t\r\n
947
+ \ <rdf:Description rdf:ID=\"manifest\">\r\n <mn:channels>\r\n <rdf:Seq>\r\n
948
+ \ <rdf:li rdf:resource=\"http://www.journaltocs.hw.ac.uk/api/journals\"
949
+ />\r\n </rdf:Seq>\r\n </mn:channels>\r\n </rdf:Description>\r\n\r\n</rdf:RDF>"
950
+ http_version:
951
+ recorded_at: Thu, 03 Sep 2015 20:09:20 GMT
952
+ recorded_with: VCR 2.9.3